š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
A study to investigate the fraction of ABT-267 and ABT-450 absorbed by the ...
Status
Completed
Location
Site Reference ID/Investigator# 118615
Start Date
2014-01
Trial ID
NCT02052362
Treatments Being Tested
The purpose of the ROAM-DBS study is to compare the time needed to achieve ...
Status
Active Not Recruiting
Location
University of Arizona Health Sciences Center
Start Date
2022-03-24
Trial ID
NCT05269862
This is a phase 2 study to evaluate the safety and tolerability of combinat...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-05-01
Trial ID
NCT04819347
Treatments Being Tested
A study to evaluate the safety and efficacy of adalimumab in Chinese subjec...
Status
Completed
Location
Site Reference ID/Investigator# 72888
Start Date
2012-08
Trial ID
NCT01646073
Treatments Being Tested
A single-arm, non-randomized, multi-center clinical study of the Amplatzerā¢...
Status
Completed
Location
CHU Trousseau
Start Date
2020-09-14
Trial ID
NCT04433520
To evaluate the safety profile, the effectiveness and the economic impact o...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00513370
Treatments Being Tested
The purpose of this clinical trial is to understand the safety and practica...
Status
Recruiting
Location
Kessler Foundation
Start Date
2024-04-08
Trial ID
NCT06773286
Treatments Being Tested
A Post-market Clinical Follow-up Study to provide safety, performance and c...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-01
Trial ID
NCT04255394
A Canadian study to evaluate early use of adalimumab after methotrexate fai...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01162421
Treatments Being Tested
The purpose of this study is to test 2 different dosing regimens of GW43390...
Status
Unknown
Location
Phoenix Body Positive
Start Date
2001-05
Trial ID
NCT00025727
Treatments Being Tested